The characteristics of drug resistant relevant genes in multidrug-resistant and extensively drug-resistant tuberculosis by fast molecular assay

Chinese Journal of Microbiology and Immunology (China)

Volumn 31, Issue 12, 2011, Pages 1133-1137

  Fan, Qi Wen ^a   Guo, Jian ^a   Zhang, Hui Zhang ^b   Wu, Xiao Yuan ^b   Hu, Xiang Nan ^a   Qian, Xue Qin ^a   Deng, Gui Lin ^a   Kang, Han ^a   Wu, Wen Juan ^a  

^a FUDAN UNIVERSITY   (China)

^b NONE

Author keywords

Drug susceptibility testing; Molecular line probe assays; Mycobacterium tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; ASSAY; BACTERIAL STRAIN; CODON; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; FAST MOLECULAR ASSAY; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; GENOTYPING TECHNIQUE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; SENSITIVITY AND SPECIFICITY;

EID: 84864390167     PISSN: 02545101     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0254-5101.2011.12.018     Document Type: Article

References (17)

1. WHO. New Laboratory Diagnostic Tools for Tuberculosis Control. WHO, 2008: 9.
2. Rüsch-Gerdes S, Pfyffer G E, Casal M, et al. Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of Mycobacterium tuberculosis to classical second-line drugs and newer antimicrobials. J Clin Microbiol, 2006, 44 (3): 688-692.
3. Krüüner A, Yates M D, Drobniewski F A. Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first- and second-line antimicrobial drugs with drug-resistant clinical strains of Mycobacterium tuberculosis. J Clin Microbiol, 2006, 44(3): 811-818.
4. Rodrigues C, Jani J, Shenai S, et al. Drug susceptibility testing of Mycobacterium tuberculosis against second-line drugs using the Bactec MGIT 960 System. Int J Tuberc Lung Dis, 2008, 12(12): 1449-1455.
5. WHO. Policy guidance on drug-susceptility testing(DST) of second-line antituberculosis drugs WHO/HTM/TB. WHO, 2008: 392.
6. Hillemann D, Rüsch-Gerdes S, Richter E. Evaluation of the Gen-oType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol, 2007, 45(8): 2635-2640.
7. Hillemann D, Rüsch-Gerdes S, Richter E. Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol, 2009, 47(6): 1767-1772.
8. WHO. Framework for Implementing New Tuberculosis Diagnostics. WHO, 2010.
9. 2011, 11(7): 759-761.
10. Ling D I, Zwerling A A, Pai M. GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur Respir J, 2008, 32(5): 1165-1174.
11. Alangaden G J, Kreiswirth B N, Aouad A, et al. Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis. Antimicrob Agents Chemother, 1998, 42(5): 1295-1297.
12. Maus C E, Plikaytis B B, Shinnick T M. Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis. Antimicrob Agents Chemother, 2005, 49(8): 3192-3197.
13. Maus C E, Plikaytis B B, Shinnick T M. Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother, 2005, 49(2): 571-577.
14. Takiff H E, Salazar L, Guerrero C, et al. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrob Agents Chemother, 1994, 38(4): 773-780.
15. Fang R, Li X, Li J, et al. Mixed infections of Mycobacterium tuberculosis in tuberculosis patients in Shanghai, China. Tuberculosis (Edinb), 2008, 88(5): 469-473.
16. Shamputa I C, Jugheli L, Sadradze N, et al. Mixed infection and clonal representativeness of a single sputum sample in tuberculosis patients from a penitentiary hospital in Georgia. Respir Res, 2006, 7: 99.
17. 2010, 33(1): 43-45.